These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3781759)

  • 21. Effects of nafamostat mesilate on ADP-induced platelet aggregation and disaggregation in hemodialysis patients.
    Miyata M; Shirakawa T; Acharya B; Terao S; Gotoh A
    ASAIO J; 2006; 52(3):272-5. PubMed ID: 16760715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic actions of prostacyclin and an isoquinoline derivative (CH-102) on ADP-induced aggregation of dog platelets in vitro.
    Pataricza J; Bor P; Szekeres L
    Biomed Biochim Acta; 1984; 43(12):1365-9. PubMed ID: 6398698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of synthetic enantiomeric cannabinoids on platelet aggregation.
    Nathan I; Agam G; Mechoulam R; Dvilansky A; Livne AA
    Can J Physiol Pharmacol; 1992 Oct; 70(10):1305-8. PubMed ID: 1337011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate.
    Akarasereenont P; Tripatara P; Chotewuttakorn S; Palo T; Thaworn A
    Platelets; 2006 Nov; 17(7):441-7. PubMed ID: 17074719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.
    Mehta P; Mehta J; Ostrowski N; Brigmon L
    J Lab Clin Med; 1983 Sep; 102(3):332-9. PubMed ID: 6411841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of a new platelet aggregation inhibitor with dissociative effect on ADP-induced platelet aggregation, from the venom of Protobothrops elegans (Sakishima-habu).
    Oyama E; Furudate N; Senuki K; Takahashi H
    Toxicon; 2009 Jun; 53(7-8):706-12. PubMed ID: 19254737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effects of cisplatin and cisplatinum (II)phosphonate complex on ADP-induced platelet aggregation in vitro.
    Kostka B; Ochocki J
    Pharmazie; 1996 Dec; 51(12):990-2. PubMed ID: 8985988
    [No Abstract]   [Full Text] [Related]  

  • 35. Lithium and rubidium activities on platelet aggregation.
    La Gioia A; Petrini M; Carulli G; Lofaro A
    Drugs Exp Clin Res; 1991; 17(6):313-6. PubMed ID: 1769320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of PGF2 alpha and caffeine on platelet aggregation by ADP induced.
    Orts Buchón A; Giménez Tomás I; Vila Pastor J; Orts Llinares A; Juan Quiles J; Esplugues Requena J
    Arch Farmacol Toxicol; 1976 Aug; 2(2):159-68. PubMed ID: 984889
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of ADP-triggered blood platelet aggregation by diadenosine polyphosphate analogues.
    Walkowiak B; Baraniak J; Cierniewski CS; Stec W
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1959-62. PubMed ID: 12113818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Classification of platelet aggregation induced by two concentrations of ADP and its clinical significance in diabetics (author's transl)].
    Matsuo T; Ohki Y; Gojo N
    Rinsho Byori; 1976 Sep; 24(9):751-4. PubMed ID: 1034054
    [No Abstract]   [Full Text] [Related]  

  • 39. Deaza analogues of adenosine as inhibitors of blood platelet aggregation.
    Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Petrelli F
    J Pharm Sci; 1984 Mar; 73(3):366-9. PubMed ID: 6716245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular components of nitrofurantoin critical to its inhibitory effect upon platelet aggregation.
    Rossi EC; Mieyal JJ; Strong JM
    Mol Pharmacol; 1975 Nov; 11(6):751-8. PubMed ID: 1207672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.